Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 4
2013 2
2014 6
2015 7
2016 2
2017 4
2018 3
2019 5
2020 4
2021 8
2022 6
2023 2
2024 4
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy.
Landi D, Bartolomeo S, Bovis F, Amato MP, Bonavita S, Borriello G, Buccafusca M, Bucello S, Cavalla P, Cellerino M, Centonze D, Cocco E, Conte A, Cortese A, D'Amico E, Di Filippo M, Docimo R, Fantozzi R, Ferraro E, Filippi M, Foschi M, Gallo A, Granella F, Ianniello A, Lanzillo R, Lorefice L, Lucchini M, Lus G, Mataluni G, Mirabella M, Moiola L, Napoli F, Nicoletti CG, Patti F, Ragonese P, Realmuto S, Schirò G, Signoriello E, Sinisi L, Stromillo ML, Tomassini V, Vecchio D, Sormani MP, Marfia GA. Landi D, et al. Among authors: realmuto s. Mult Scler. 2024 Oct;30(11-12):1503-1513. doi: 10.1177/13524585241274600. Epub 2024 Sep 12. Mult Scler. 2024. PMID: 39263885
Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple Sclerosis.
Portaccio E, Betti M, De Meo E, Pastò L, Prestipino E, Lugaresi A, Cocco E, De Luca G, Patti F, Torri Clerici VLAM, Ferraro D, Brescia Morra V, Salemi G, Vianello M, Cerqua R, Inglese M, Pasanisi MB, Perini P, Romano S, Pozzilli C, Tortorella C, Di Sapio A, Annovazzi P, Simone M, Iaffaldano P, Rocca MA, Filippi M, Trojano M, Amato MP; Italian Multiple Sclerosis and Related Disorders Register. Portaccio E, et al. Neurology. 2025 Oct 21;105(8):e213977. doi: 10.1212/WNL.0000000000213977. Epub 2025 Sep 22. Neurology. 2025. PMID: 40982769 Free PMC article.
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries.
Sharmin S, Roos I, Malpas CB, Iaffaldano P, Simone M, Filippi M, Kubala Havrdova E, Ozakbas S, Brescia Morra V, Alroughani R, Zaffaroni M, Patti F, Eichau S, Salemi G, Di Sapio A, Inglese M, Portaccio E, Trojano M, Amato MP, Kalincik T; Writing Group; Italian Multiple Sclerosis and Related Disorders Register and MSBase Study Group. Sharmin S, et al. Lancet Child Adolesc Health. 2024 May;8(5):348-357. doi: 10.1016/S2352-4642(24)00047-6. Epub 2024 Mar 25. Lancet Child Adolesc Health. 2024. PMID: 38547883
[Registers as central real world data source: the experience of the Italian Multiple Sclerosis and Related Disorders Register].
Ponzio M, Battaglia MA, Trojano M, Salivetto M, D'Ettorre A, Corrado D, Paletta P, Lepore V, Mosconi P; Comitato Scientifico del Registro Italiano Sclerosi Multipla e Patologie Correlate; Rete dei centri del Registro Italiano Sclerosi Multipla e Patologie Correlate; Rete degli assistenti di ricerca del Registro Italiano Sclerosi Multipla e Patologie Correlate. Ponzio M, et al. Epidemiol Prev. 2024 Jul-Oct;48(4-5):361-374. doi: 10.19191/EP24.4-5.A734.074. Epidemiol Prev. 2024. PMID: 39329242 Free article. Italian.
Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.
Haggiag S, Prosperini L, Filippi M, Rocca MA, Iaffaldano P, Patti F, Inglese M, Borriello G, Totaro R, Lus G, Fantozzi R, Brescia Morra V, Romano S, Frau J, Marfia GA, Maniscalco GT, Amato MP, Di Sapio A, De Luca G, Crisafulli SG, Curti E, Foschi M, Cavalla P, Salemi G, Conte A, Valentino P, Ferraro D, Lugaresi A, Realmuto S, Perini P, Ferraro E, Montepietra S, Avolio C, Vianello M, Gazzola P, Marinelli F, Pasquali L, Bucello S, Vecchio D, Protti A, Sangalli F, Rovaris M, Grimaldi L, De Riz M, Barone P, Scarano V, Ardito B, Sinisi L, Immovilli P, Pesci I, Colombo E, Capobianco MA, Fioretti C, Coniglio MG, Giordano A, Tassinari T, Cargnelutti D, Matta F, Falcini M, Gatto M, Mascoli N, Balgera R, Sessa E, Iodice R, Solaro C, Plewnia K, Santangelo M, Barcella V, Ferrò MT, Sica F, Cerqua R, Santuccio G, Corea F, Leone A, Nasuelli D, Rini AM, Brichetto G, Cottone S, Ulivelli M, Pizzorno M, Rossi P, Milano E, Zuliani L, Ruggieri S, Gasperini C, Trojano M, Tortorella C. Haggiag S, et al. Among authors: realmuto s. JAMA Netw Open. 2025 Nov 3;8(11):e2541025. doi: 10.1001/jamanetworkopen.2025.41025. JAMA Netw Open. 2025. PMID: 41182765 Free PMC article.
Real-world effectiveness and safety of ofatumumab in relapsing-remitting multiple sclerosis: Insights from naïve and switch patients.
Chisari CG, Lo Fermo S, Iacono S, Schirò G, Ruscica F, Realmuto S, Bucello S, Ragonese P, Salemi G, Matta F, Toscano S, Cottone S, Edoardo Grimaldi LM, Patti F. Chisari CG, et al. Among authors: realmuto s. Neurotherapeutics. 2025 Oct;22(6):e00724. doi: 10.1016/j.neurot.2025.e00724. Epub 2025 Sep 15. Neurotherapeutics. 2025. PMID: 40957770 Free PMC article.
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY).
Chisari CG, Bianco A, Brescia Morra V, Calabrese M, Capone F, Cavalla P, Chiavazza C, Comi C, Danni M, Filippi M, Iaffaldano P, Lanzillo R, Lo Fermo S, Lucisano A, Lugaresi A, Lus G, Marfia GA, Marinelli F, Mirabella M, Moiola L, Perin C, Realmuto S, Toscano S, Trojano M, Vecchio D, Patti F; Italian MS Registry. Chisari CG, et al. Among authors: realmuto s. Neurotherapeutics. 2023 Oct;20(6):1696-1706. doi: 10.1007/s13311-023-01415-y. Epub 2023 Aug 23. Neurotherapeutics. 2023. PMID: 37610702 Free PMC article.
Signs and symptoms of COVID-19 in patients with multiple sclerosis.
Schiavetti I, Carmisciano L, Ponzano M, Cordioli C, Cocco E, Marfia GA, Inglese M, Filippi M, Radaelli M, Bergamaschi R, Immovilli P, Capobianco M, De Rossi N, Brichetto G, Scandellari C, Cavalla P, Pesci I, Confalonieri P, Perini P, Trojano M, Lanzillo R, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M, Sormani MP; MuSC-19 Study Group. Schiavetti I, et al. Eur J Neurol. 2022 Dec;29(12):3728-3736. doi: 10.1111/ene.15554. Epub 2022 Sep 23. Eur J Neurol. 2022. PMID: 36086905 Free PMC article.
50 results